Essilor R&D Centre Singapore
Singapore
NCT Number: NCT07839091
The purpose of this clinical trial is to compare a new myopia control spectacle lens with a standard single vision spectacle lens in slowing the progression of myopia (nearsightedness) in healthy children aged 6 to under 11 years.
The main question being studied is:
Is the new myopia control spectacle lens more effective than a standard single vision spectacle lens in slowing myopia progression?
In this study, participants will wear a myopia control spectacle lens in one eye and a standard single vision spectacle lens in the other eye for the first 6 months. The lens assignment will then be switched between eyes for the remaining 6 months. Researchers will compare changes in eye axial length and refractive error between the two lens types.
Participants will:
* Wear the study spectacles for 12 months. * Attend scheduled follow-up visits at the Essilor R&D Centre, Singapore.
Trial opening soon.
Get Notified6 year–10 year
All sexes
Interventional
Not applicable
Singapore
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
A spectacle lens designed to help slow the progression of myopia in children
A standard spectacle lens used to correct refractive error without a specific myopia control feature
Time frame: From baseline to 6 months
Time frame: From 6 months to 12 months
Time frame: From baseline to 6 months
Time frame: From 6 months to 12 months
Trial opening soon.
Get NotifiedEssilor International
Industry
A Paired-Eye Comparison of Myopia Control Lenses in Myopic Children
Acronym: PEARL
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06631339
Eye Diseases, Light; Therapy, Complications
Singapore
View Trial DetailsNCT07747311
Eye Diseases, Myopia
Berkeley, California, United States
View Trial DetailsNCT07683481
Behavior, Eye Diseases
View Trial DetailsNCT07647146
Astigmatism, Corneal Diseases
Sohag, Sohag Governorate, Egypt
View Trial Details